This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, Y. Articles by Xie, D. Search for Related Content PubMed PubMed Citation Articles by Wang, Y. Articles by Xie, D.

Negative Feedback Regulation of IFN- Pathway by IFN Regulatory Factor 2 in Esophageal Cancers

¹ Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China; ² College of Public Health, Zhengzhou University, Zhengzhou, China; ³ Department of Hematology and Oncology, Cedars-Sinai Medical Center, University of California at Los Angeles School of Medicine, Los Angeles, California; and ⁴ College of Life Sciences, Beijing University, Beijing, China

Requests for reprints: Dong Xie, Laboratory of Molecular Oncology, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 294 Tai-Yuan Road, Shanghai 200031, People's Republic of China. Phone: 86-21-54920918; Fax: 86-21-54920291; E-mail: dxie{at}sibs.ac.cn.

Key Words: ESCC • IFN- • IFNGR1 • IRF-1 • IRF-2

IFN- is an antitumor cytokine that inhibits cell proliferation and induces apoptosis after engagement with the IFN- receptors (IFNGR) expressed on target cells, whereas IFN regulatory factor 2 (IRF-2) is able to block the effects of IFN- by repressing transcription of IFN-–induced genes. Thus far, few studies have explored the influences of IFN- on human esophageal cancer cells. In the present study, therefore, we investigated in detail the functions of IFN- in esophageal cancer cells. The results in clinical samples of human esophageal cancers showed that the level of IFN- was increased in tumor tissues and positively correlated with tumor progression and IRF-2 expression, whereas the level of IFNGR1 was decreased and negatively correlated with tumor progression and IRF-2 expression. Consistently, in vitro experiments showed that low concentration of IFN- induced the expression of IRF-2 with potential promotion of cell growth, and moreover, IRF-2 was able to suppress IFNGR1 transcription in human esophageal cancer cells by binding a specific motif in IFNGR1 promoter, which lowered the sensitivity of esophageal cancer cells to IFN-. Taken together, our results disclosed a new IRF-2–mediated inhibitory mechanism for IFN-–induced pathway in esophageal cancer cells: IFN- induced IRF-2 up-regulation, then up-regulated IRF-2 decreased endogenous IFNGR1 level, and finally, the loss of IFNGR1 turned to enhance the resistance of esophageal cancer cells to IFN-. Accordingly, the results implied that IRF-2 might act as a mediator for the functions of IFN- and IFNGR1 in human esophageal cancers. [Cancer Res 2008;68(4):1136–43]

This article has been cited by other articles:

				Y Shi, X Ding, Z-H He, K-C Zhou, Q Wang, and Y-Z Wang Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer Gut, November 1, 2009; 58(11): 1443 - 1450. [Abstract] [Full Text] [PDF]